Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1986-6-13
pubmed:abstractText
The clone TA10 is a T3+ T4+ T8- proliferative and cytolytic human T cell clone. This clone has been shown to be specific for the hemagglutinin of influenza A Texas virus and restricted by an HLA class II molecule associated with the DRw8-Dw8.1 phenotype. Here we show that TA10 and all of its subclones can also react with eight HLA-DRw8 negative, Epstein-Barr virus (EBV)-transformed cell lines or phytohemagglutinin blasts in the absence of influenza antigens. All of these cell lines are HLA-DR2/DR4 with a classic DR2 long haplotype. The only nonreactive HLA-DR2/DR4 cell line observed bears a DR2 short haplotype. Only heterozygous HLA-DR2/DR4 but not parental DR2 or DR4 EBV-transformed cell lines can be recognized by TA10, indicating that the cross-reacting determinant is a transcomplementation product between HLA-DR2 and HLA-DR4 haplotypes. DR-specific, but not DQ- or DP-specific monoclonal antibodies, inhibit in the proliferation assay and in the chromium release test both the DRw8-Dw8.1-restricted and the anti-DR2/DR4 reactions. These results show that HLA-DR-restricted, anti-viral human T cell clone can evidence cross-reactivity for allospecific class II molecules of the major histocompatibility complex, and human CTL can recognize transcomplementation products of class II HLA genes. In addition, the results suggest that a beta-chain coded for by an HLA-DR gene and associated with an alpha-chain coded for by a still unidentified but possibly HLA-DQ gene constitute this functional transcomplementation product.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3961-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:2422266-Antibodies, Monoclonal, pubmed-meshheading:2422266-Binding, Competitive, pubmed-meshheading:2422266-Cell Line, pubmed-meshheading:2422266-Cell Transformation, Viral, pubmed-meshheading:2422266-Clone Cells, pubmed-meshheading:2422266-Cross Reactions, pubmed-meshheading:2422266-Cytotoxicity Tests, Immunologic, pubmed-meshheading:2422266-Epitopes, pubmed-meshheading:2422266-Genotype, pubmed-meshheading:2422266-HLA-DR Antigens, pubmed-meshheading:2422266-HLA-DR Serological Subtypes, pubmed-meshheading:2422266-HLA-DR2 Antigen, pubmed-meshheading:2422266-HLA-DR4 Antigen, pubmed-meshheading:2422266-Herpesvirus 4, Human, pubmed-meshheading:2422266-Histocompatibility Antigens Class II, pubmed-meshheading:2422266-Humans, pubmed-meshheading:2422266-Influenza A virus, pubmed-meshheading:2422266-Lymphocyte Activation, pubmed-meshheading:2422266-T-Lymphocytes, Cytotoxic
pubmed:year
1986
pubmed:articleTitle
An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
pubmed:publicationType
Journal Article